Stay updated with breaking news from Jonathan Silcock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As the National Health Service launches its spring COVID-19 vaccination campaign, significantly fewer people will have access to a free jab and must pay for one or do without.
The problem is tricky to treat and outbreaks are more common in group-living situations such as care homes, nurseries and university halls of residence.
Tirzepatide, which is sold under the brand name Mounjaro, has been approved for use by diabetes patients in the UK and its manufacturer hopes approval for weight loss treatment will follow
Jonathan Silcock, 37, and his family are now determined to make the most of the time ahead of them after the shocking discovery.
Medicine is responsible for more emissions than the car industry, with the worst culprits drugs we use (and overuse) every day